Press
21 December, 2009
Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans
+ Click here for Press Release
Press
17 December, 2009
Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
+ Click here for Press Release
Press
9 November, 2009
Cardiome Reports Third Quarter Results
+ Click here for Press Release
Press
6 November, 2009
Cardiome to Release Third Quarter Results
+ Click here for Press Release
Press
2 November, 2009
Cardiome to Present at Oppenheimer Healthcare Conference
+ Click here for Press Release
Press
28 October, 2009
Cardiome and Astellas Announce Initiation of Patient Enrolment in ACT 5 Trial
+ Click here for Press Release
Press
16 October, 2009
Cardiome Pharma Corp. Announces Final Results of Tender Offer
+ Click here for Press Release
Press
14 October, 2009
Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer
+ Click here for Press Release
Press
2 October, 2009
Cardiome to Present at JMP Securities Healthcare Conference
+ Click here for Press Release
Press
25 September, 2009
Cardiome Pharma Corp. Announces New Expiration Date for Tender Offer
+ Click here for Press Release
Press
25 September, 2009
Cardiome Announces Next Steps for GED-aPC Asset and Transition of Dr. Charles Fisher to Consulting Role
+ Click here for Press Release
Press
1 September, 2009
Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
+ Click here for Press Release
Press
28 August, 2009
Cardiome Announces Upcoming Presentation of Results of Phase 2b Clinical Trial of Vernakalant (oral) at the European Society of Cardiology Congress 2009
+ Click here for Press Release
Press
25 August, 2009
Cardiome Pharma Corp. Announces Tender Offer to Purchase Up To US$27.5 Million Of Its Common Shares
+ Click here for Press Release
Press
11 August, 2009
Cardiome Reports Second Quarter Results
+ Click here for Press Release
Press
10 August, 2009
Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement
+ Click here for Press Release
Press
10 August, 2009
Cardiome to Hold Conference Call
+ Click here for Press Release
Press
3 August, 2009
Cardiome Announces Management Transition
+ Click here for Press Release
Press
28 July, 2009
Cardiome Achieves Milestone From Collaboration With Merck & Co., Inc.
+ Click here for Press Release
Press
19 May, 2009
Cardiome Announces That Collaboration and License Agreement With Merck & Co., Inc. Now Effective
+ Click here for Press Release
Press
15 May, 2009
Cardiome Reports First Quarter Results
+ Click here for Press Release
Press
8 April, 2009
Cardiome to Hold Conference Call
+ Click here for Press Release
Press
8 April, 2009
Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation
+ Click here for Press Release
Press
30 March, 2009
Cardiome Reports 2008 Results
+ Click here for Press Release